Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis.

Emanuele D'AmicoAurora ZanghìMariangela SciandraRoberta LanzilloGraziella CallariAntonio CorteseGiacomo LusMatteo LucchiniMaria BuccafuscaSimona BonavitaAntonio GalloErica CurtiAlberto GajofattoElisabetta SignorielloAlvino BiseccoFrancesca GobbinMaria Teresa FerròGina FerrazzanoMaddalena SparacoPaola ValentinoMassimiliano MirabellaFranco GranellaVincenzo BresciamorraLuigi Maria Edoardo GrimaldiFrancesco Pattinull null

Published in: Journal of neurology (2020)

Patients on DMF had higher relapse-free survival time than TRF group after the first 38 months on therapy.

Keyphrases

free survival
data analysis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes
patient reported
cell therapy